Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by State Street Corp

State Street Corp lessened its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 3.6% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 904,901 shares of the company's stock after selling 33,324 shares during the period. State Street Corp owned about 2.23% of Phibro Animal Health worth $20,378,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Quantbot Technologies LP purchased a new stake in Phibro Animal Health in the third quarter worth about $70,000. nVerses Capital LLC purchased a new position in Phibro Animal Health during the 3rd quarter valued at approximately $70,000. China Universal Asset Management Co. Ltd. increased its stake in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after acquiring an additional 1,522 shares during the last quarter. CWM LLC raised its holdings in shares of Phibro Animal Health by 190.8% during the 3rd quarter. CWM LLC now owns 6,363 shares of the company's stock worth $143,000 after acquiring an additional 4,175 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in shares of Phibro Animal Health during the 2nd quarter worth approximately $193,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on PAHC. Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Barclays raised their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a report on Tuesday, September 10th. They set a "neutral" rating and a $22.00 price objective for the company. StockNews.com upgraded Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a research report on Wednesday, December 18th. Finally, Bank of America upped their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a report on Friday, August 30th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $20.50.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC remained flat at $21.64 during midday trading on Tuesday. 60,041 shares of the stock were exchanged, compared to its average volume of 160,458. Phibro Animal Health Co. has a 1 year low of $10.03 and a 1 year high of $25.98. The stock's 50 day moving average is $23.52 and its 200 day moving average is $20.77. The stock has a market cap of $876.48 million, a P/E ratio of 50.33, a price-to-earnings-growth ratio of 0.58 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health's dividend payout ratio is currently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.